Neogen Corp. (NEOG)
11.25
+0.16
(+1.44%)
USD |
NASDAQ |
Feb 24, 14:38
Neogen Research and Development Expense (Quarterly) : 4.563M for Nov. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Teleflex, Inc. | 57.23M |
| AbbVie, Inc. | 2.579B |
| Prestige Consumer Healthcare, Inc. | -- |
| Outlook Therapeutics, Inc. | 3.634M |
| Organon & Co. | 91.00M |